(Q35319271)

7 August 2017

title

Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China (English)

1 reference

7 August 2017

Li-Chen Tang

1

1 reference

7 August 2017

Xi Jin

2

1 reference

7 August 2017

Hai-Yuan Yang

3

1 reference

7 August 2017

Min He

4

1 reference

7 August 2017

Helena Chang

5

1 reference

7 August 2017

Zhi-Ming Shao

6

1 reference

7 August 2017

Gen-Hong Di

7

1 reference

7 August 2017

language of work or name

English

0 references

publication date

29 March 2015

1 reference

7 August 2017

1 reference

7 August 2017

volume

15

1 reference

7 August 2017

page(s)

201

1 reference

Creative Commons Attribution 4.0 International

7 August 2017

copyright license

start time

29 March 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Breast cancer in China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Cancer incidence and survival among adolescents and young adults in Korea

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

12 July 2018

Cancer statistics, 2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Comparison of Clinical Features and Treatment Outcome of Breast Cancers in Young and Elderly Chinese Patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Young age: an independent risk factor for disease-free survival in women with operable breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Clinical features and survival analysis of very young (age<35) breast cancer patients

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Unfavourable clinicopathologic features and low response rate to systemic adjuvant therapy: results with regard to poor survival in young Chinese breast cancer patients.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

REporting recommendations for tumor MARKer prognostic studies (REMARK).

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Changes and problematic areas in interpretation of the AJCC Cancer Staging Manual, 6th Edition, for breast cancer.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Do young breast cancer patients have worse outcomes?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Very young women (<35 years) with operable breast cancer: features of disease at presentation.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

BRCA-associated breast cancer in young women

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4389816

Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25885213

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Stage 0 to stage III breast cancer in young women

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25885213

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25885213

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S12885-015-1207-Z

1 reference

Dimensions Publication ID

7 August 2017

0 references

1 reference

7 August 2017

1 reference